|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-3-26
|
|
pubmed:abstractText |
Short courses of intermittent pulse cyclophosphamide (CY) have mitigated ovarian toxicity but have also led to incomplete or unsustained remissions of active systemic lupus erythematosus (SLE) in many patients, prompting an evaluation of the immunologic effects of this regimen in the NZB/W female mouse (B/W) model of human SLE.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
61-8
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9002012-Adjuvants, Immunologic,
pubmed-meshheading:9002012-Animals,
pubmed-meshheading:9002012-Antibodies, Antinuclear,
pubmed-meshheading:9002012-Antibody Formation,
pubmed-meshheading:9002012-Cyclophosphamide,
pubmed-meshheading:9002012-Disease Models, Animal,
pubmed-meshheading:9002012-Drug Administration Schedule,
pubmed-meshheading:9002012-Female,
pubmed-meshheading:9002012-Injections, Intraperitoneal,
pubmed-meshheading:9002012-Lupus Erythematosus, Systemic,
pubmed-meshheading:9002012-Lymphocyte Subsets,
pubmed-meshheading:9002012-Mice,
pubmed-meshheading:9002012-Mice, Inbred NZB,
pubmed-meshheading:9002012-Spleen
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
|
|
pubmed:affiliation |
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1268, USA.
|
|
pubmed:publicationType |
Journal Article
|
